Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-12-19Clinical Trial Update: Metformin Therapy for Overweight Adolescents With Type 1 Diabetes [Phase 3]
Phase 3 clinical trial evaluating metformin therapy for overweight adolescents with Type 1 diabetes has completed with results posted.
-
FDA approval · 2018-12-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental Biologics License Application for insulin lispro from Eli Lilly, authorizing changes to the product's labeli…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: Obtain a Good Blood Glucose Control With the Paradigm Real Time System [NA]
Clinical trial update for the Paradigm Real Time System aimed at achieving good blood glucose control in individuals with Type 1 Diabetes; s…
-
FDA approval · 2018-11-29FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) submitted by sanofi-aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion [NA]
Clinical trial update reporting on the effect of canagliflozin in Type 1 diabetes after interruption of continuous subcutaneous insulin infu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2) [Phase 3]
Phase 3 trial update for empagliflozin added to insulin in type 1 diabetes over 52 weeks (EASE-2) with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-20Clinical Trial Update: Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes [Phase 4]
Phase 4 clinical trial assessing whether urinary alkalinization affects urine uric acid precipitation and crystallization in adults with typ…
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression [Phase 1, Phase 2]
Phase 1/2 trial evaluating islet transplantation in Type 1 diabetes using the Edmonton Protocol with steroid-free immunosuppression; study c…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients [Phase 3]
Phase 3 trial update on G-Pen glucagon injection for pediatric type 1 diabetes; results completed and posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes [Phase 4]
Phase 4 trial comparing diabetes care management to standard care in adolescents and young adults with Type 1 diabetes has completed.
-
FDA approval · 2018-11-06FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin 70/30 (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2018-11-06Clinical Trial Update: Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes [Phase 3]
Phase 3 trial update for dapagliflozin in patients with inadequately controlled Type 1 diabetes; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) [Phase 3]
Phase 3 trial assessing empagliflozin as an adjunct to insulin in adults with type 1 diabetes over 26 weeks has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus [Phase 1]
Phase 1 trial update evaluating the effect of a fixed pramlintide:insulin dose ratio on postprandial glucose in type 1 diabetes.
-
FDA approval · 2018-11-01FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for INSULIN LISPRO submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Study of LY2409021 in Participants With Type 1 Diabetes [Phase 1]
Phase 1 clinical trial update for LY2409021 in participants with Type 1 diabetes; study completed and results posted.
-
FDA approval · 2018-10-25FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Toujeo (insulin glargine) filed by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2018-10-25FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
FDA approves a supplemental application for AFREZZA (insulin human) from MannKind Corporation.
-
FDA approval · 2018-10-19FDA Approved: ADMELOG — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for ADMELOG (insulin lispro) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes [Phase 2]
Phase II clinical trial evaluating efficacy and safety of Glassia for new onset type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes [EARLY_Phase 1]
Early-phase trial evaluating modulating STAT3 signaling with siltuximab in Type 1 Diabetes completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics [Phase 3]
A Phase 3 trial comparing G-Pen to Lilly Glucagon for hypoglycemia rescue in adults with Type 1 diabetes has completed with posted results.
-
FDA approval · 2018-09-26FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) filed by Eli Lilly and Company. The action supplements the…
-
FDA approval · 2018-09-26FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2018-09-24Clinical Trial Update: Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes [Phase 2]
A Phase 2 clinical trial update for an azithromycin insulin diet intervention in Type 1 diabetes is listed, with unknown status.